Search Page

1

Cite

CRISPR-Cas9 for cancer therapy: Opportunities and challenges.

Chen M, Mao A, Xu M, Weng Q, Mao J, Ji J. Chen M, et al. Cancer Lett. 2019 Apr 10;447:48-55. doi: 10.1016/j.canlet.2019.01.017. Epub 2019 Jan 23. Cancer Lett. 2019. PMID: 30684591 Review.

Cite

2

Cite

Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: roles, opportunities and challenges.

Ding JY, Chen MJ, Wu LF, Shu GF, Fang SJ, Li ZY, Chu XR, Li XK, Wang ZG, Ji JS. Ding JY, et al. Mil Med Res. 2023 Aug 17;10(1):36. doi: 10.1186/s40779-023-00472-w. Mil Med Res. 2023. PMID: 37587531 Free PMC article. Review.

Cite

3

Cite

Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 Response.

Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, Xu Z, Yang Y, Weng Q, Zhao Z, Chen M, Ji J. Tang B, et al. Among authors: chen m. Adv Sci (Weinh). 2023 Jan;10(2):e2203973. doi: 10.1002/advs.202203973. Epub 2022 Nov 28. Adv Sci (Weinh). 2023. PMID: 36442849 Free PMC article.

Cite

4

Cite

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.

Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S, Zhao Z, Tu J, Chen M, Ji J. Zhang X, et al. Among authors: chen m. Mol Cancer. 2024 Nov 15;23(1):255. doi: 10.1186/s12943-024-02130-8. Mol Cancer. 2024. PMID: 39543600 Free PMC article. Review.

Cite

5

Cite

Precision interventional radiology.

Ji J, Fang S, Minjiang Chen, Liyun Zheng, Chen W, Zhao Z, Cheng Y. Ji J, et al. Among authors: minjiang chen. J Interv Med. 2021 Dec 23;4(4):155-158. doi: 10.1016/j.jimed.2021.09.002. eCollection 2021 Nov. J Interv Med. 2021. PMID: 35586378 Free PMC article.

Cite

6

Cite

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives.

Zhang XB, Fan YB, Jing R, Getu MA, Chen WY, Zhang W, Dong HX, Dakal TC, Hayat A, Cai HJ, Ashrafizadeh M, Abd El-Aty AM, Hacimuftuoglu A, Liu P, Li TF, Sethi G, Ahn KS, Ertas YN, Chen MJ, Ji JS, Ma L, Gong P. Zhang XB, et al. Mil Med Res. 2024 Jun 4;11(1):35. doi: 10.1186/s40779-024-00535-6. Mil Med Res. 2024. PMID: 38835066 Free PMC article. Review.

Cite

7

Cite

Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma.

Chen M, Ma P, Zhang Y, Wang D, Yu Z, Fu Y, Zhao X, Wang M, Zhuang G, Jing Y. Chen M, et al. J Immunother Cancer. 2023 Oct;11(10):e007305. doi: 10.1136/jitc-2023-007305. J Immunother Cancer. 2023. PMID: 37857527 Free PMC article.

Cite

8

Cite

Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy.

Tang B, Zhu J, Shi Y, Wang Y, Zhang X, Chen B, Fang S, Yang Y, Zheng L, Qiu R, Weng Q, Xu M, Zhao Z, Tu J, Chen M, Ji J. Tang B, et al. Among authors: chen m. Mol Cancer. 2024 Jul 5;23(1):137. doi: 10.1186/s12943-024-02049-0. Mol Cancer. 2024. PMID: 38970074 Free PMC article.

Cite

9

Cite

Hybrid hair follicle stem cell extracellular vesicles co-delivering finasteride and gold nanoparticles for androgenetic alopecia treatment.

Wu X, Huang X, Zhu Q, Zhang J, Hu J, Song Y, You Y, Zhu L, Lu J, Xu X, Chen M, Wang W, Song X, Ji J, Du Y. Wu X, et al. Among authors: chen m. J Control Release. 2024 Sep;373:652-666. doi: 10.1016/j.jconrel.2024.07.066. Epub 2024 Aug 1. J Control Release. 2024. PMID: 39089503

Cite

10

Cite

Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors.

Liu X, Lu B, Tang H, Jia X, Zhou Q, Zeng Y, Gao X, Chen M, Xu Y, Wang M, Tan B, Li J. Liu X, et al. Among authors: chen m. EBioMedicine. 2024 Nov;109:105427. doi: 10.1016/j.ebiom.2024.105427. Epub 2024 Oct 30. EBioMedicine. 2024. PMID: 39471749 Free PMC article.

Cite